Hemosiderosis

Jump to: navigation, search
Hemosiderosis
ICD-9 516.1
OMIM 178550
DiseasesDB 29717

Hemosiderosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemosiderosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemosiderosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemosiderosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemosiderosis

CDC on Hemosiderosis

Hemosiderosis in the news

Blogs on Hemosiderosis

Directions to Hospitals Treating Hemosiderosis

Risk calculators and risk factors for Hemosiderosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and Keywords: Idiopathic pulmonary hemosiderosis; IPH; hemosiderin accumulation; Pulmonary hemosiderosis; Pulmonary haemosiderosis; Essential brown induration of lung; Brown induration of lung; Ceelen-Gellerstedt syndrome

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemosiderosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Related Chapters


Linked-in.jpg